D-0521-2016 Class III Terminated

Recalled by Teva Pharmaceutical Industries — Jerusalem, N/A

Recall Details

Product Type
Drugs
Report Date
December 23, 2015
Initiation Date
October 20, 2015
Termination Date
November 1, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3536 bottles

Product Description

Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES LTD Jerusalem, 971010 Israel, Manufactured for: TEVA PHARMACEUTICAL INDUSTRIES USA Sellersville, PA 18960. NDC 0093-8238-98

Reason for Recall

Labeling: Incorrect or Missing Lot AND/OR Exp Date.

Distribution Pattern

Nationwide

Code Information

Lot #: 24I030, Exp 5/2017